The global oxygen therapy market is anticipated to reach US$18.90 billion in 2024 growing at a CAGR of 11.91% during the period spanning 2020-2024.

The global antiviral drugs market is expected to reach US$70.95 billion in 2024, increasing at a CAGR of 2.10%, for the duration of 2020-2024.

The global infrared camera market is expected to reach US$11.54 billion in 2024, witnessing growth at a CAGR of 7.60%, over the period 2020-2024.

The global antiretroviral therapy market is anticipated to reach US$35.14 billion in 2024. The market is predicted to experience growth at a CAGR of 3.40% during the period spanning 2020-2024.

The global intensive care beds market is estimated to reach US$4.14 billion in 2024, growing at a CAGR of 4.21% for the period spanning from 2020 to 2024.

The global infrared thermometer market is forecasted to reach US$16.4 million in 2024, growing at a CAGR of 7.48%, for the period spanning from 2020 to 2024.

The global surgical gowns market is expected to reach US$2.10 billion in 2024. The market is predicted to witness growth at a CAGR of 5.27%, during the period spanning 2020-2024.

The global infectious diseases diagnostics market reached US$24.32 billion in 2024, growing at a CAGR of 3.30% for the duration spanning 2020-2024.

The global BCG vaccine market is anticipated to reach US$65.53 million in 2024, growing at a CAGR of 4.70% during the period spanning 2020-2024.

The global molecular diagnostics market is estimated to reach US$17.96 billion in 2024, growing at a CAGR of 6.16% for the period spanning from 2020 to 2024.

The global telehealth market is forecasted to reach US$20.18 billion in 2024, growing at a CAGR of 7.95% for the period spanning 2020-2024.

The global non-alcoholic steatohepatitis (NASH) drugs market is expected to reach US$84.34 billion in 2029, growing at a CAGR of 39.13%, for the duration spanning 2018-2029.

The global robotic surgery market is forecasted to reach US$6.84 billion in 2024, growing at a CAGR of 14.79% for the period spanning 2020-2024.

The global monoclonal antibodies market is expected to reach US$161.7 billion in 2024, increasing at a CAGR of 7.21%, for the duration of 2020-2024.

The global dialysis market is estimated to reach US$127.4 billion in 2024, growing at a CAGR of 6.29% for the period spanning from 2020 to 2024.

The global endoscopy market is predicted to reach US$41.15 billion in 2024, witnessing growth at a CAGR of 6.75%, over the period 2020-2024.

The US acne market is expected to reach US$4.49 billion in 2024, recording growth at a CAGR of 4.12% during the period spanning 2019-2024.

The global gene therapy market is expected to reach US$6.42 billion in 2024, witnessing growth at a CAGR of 19.29%, over the period 2020-2024.

The Nordic fitness market is estimated to reach US$3.13 billion in 2024, growing at a CAGR of 3.86% for the period spanning 2020-2024.

The global migraine market is expected to reach US$5.10 billion in 2024, growing at a CAGR of 3.7%, for the duration spanning 2020-2024

The global inhaled nitric oxide market is predicted to reach US$1.22 billion in 2024, witnessing growth at a CAGR of 5.90%, over the period 2020-2024.

The global microbiomes market is forecasted to reach US$9,376 million in 2024, growing at a CAGR of 135.47% for the period spanning 2018-2024.

The global hemophilia market is anticipated to reach US$13.86 billion in 2024, growing at a CAGR of 5.61% during the period spanning 2020-2024.

The global prostate cancer market is anticipated to reach US$14.41 billion in 2024, witnessing growth at a CAGR of 4.62%, over the period 2020-2024.

The global e-cigarette market is forecasted to reach US$76.82 billion in 2024, growing at a CAGR of 18.51% for the period spanning 2020-2024.

The global steel production volume is estimated to reach 2175 million tones in 2024, growing at a CAGR of 4.50% for the period spanning from 2020 to 2024.

Asia Pacific beer market is anticipated to grow at a CAGR of 4.84% during the period spanning 2020-2024. The market in 2024 is forecasted to be US$240.7 billion.

The global nucleic acid therapeutics market is expected to record a value of US$7.23 billion in 2024, increasing at a CAGR of 33.3%, for the duration spanning 2020-2024.